Posttraumatic stress disorder (PTSD) is a severe and often chronic anxiety disorder that can develop following exposure to an event involving actual or perceived threat to the life or physical integrity of oneself or another person. Epidemiological studies such as the National Comorbidity Survey1 estimate that more than half the population of the United States has experienced one or more traumatic events and that 8% of the population has met criteria for lifetime PTSD. Thus, trauma and PTSD are significant mental health problems.
In this article, we provide a summary of research on the efficacy of treatments for PTSD and suggest directions for future work. Although numerous psychological therapies have been suggested and used in patients with PTSD, most efficacy research using gold standard randomized controlled treatment methodology2 has focused on various cognitive-behavioral therapy (CBT) programs. Accordingly, our review will also focus on CBT.
Description of CBT procedures
CBT is a broad term covering a number of interventions designed to challenge and modify erroneous cognitions, reduce the intensity and frequency of distressing negative emotional reactions via exposure to safe but feared situations and objects, and promote effective coping. Two erroneous cognitions commonly found in patients with PTSD are that the world is entirely dangerous and that the person with PTSD is incompetent.3 CBT is a short-term approach, usually involving 9 to 12 individual sessions lasting 60 to 90 minutes, and administered once or twice weekly. Patients are usually assigned homework to practice the specific interventions between sessions.
The most frequently used interventions for PTSD are exposure therapy, stress inoculation training (SIT), and cognitive restructuring. These interventions may be administered as stand-alone treatments or combined into a more comprehensive treatment package. A fourth treatment for PTSD, eye movement desensitization and reprocessing (EMDR),4 incorporates elements of exposure and cognitive restructuring with therapist-directed rapid eye movements or other laterally alternating activities.
Exposure therapy is a set of treatment procedures designed to help individuals confront feared but safe thoughts, situations, objects, people, places, or activities that elicit anxiety or are otherwise avoided because they are perceived as dangerous by patients with PTSD. Exposure to feared but safe situations is a major component of treatment for other anxiety disorders such as phobias, social anxiety disorder, obsessive-compulsive disorder, and panic disorder/ agoraphobia.5
For PTSD, exposure therapy typically involves imaginal exposure to the trauma memory in which patients are instructed to close their eyes and recall the traumatic event by imagining that it is happening right now while simultaneously describing out loud what is being remembered. Patients are encouraged to provide a detailed description of the memory, including all important sights, sounds, smells, tastes, and physical sensations, along with thoughts and emotional reactions that occurred during the trauma. These trauma narratives are repeated several times in the therapy session over the course of 20 to 45 minutes and recorded for the patient to listen to as daily homework.
In addition to imaginal exposure, patients practice in vivo exposure to real life stimuli that trigger trauma-related memories and distress.6 This is accomplished through identifying the people, places, situations, and activities that trigger anxiety and avoidance because of the trauma; evaluating each one for safety and for relevance to the patient's normal functioning; then repeatedly confronting selected situations for prolonged periods until there is a significant reduction in the patient's anxiety. To facilitate in vivo exposure, a hierarchy is constructed that begins with targets of moderate difficulty and then moves gradually to more challenging targets as the patient succeeds with the lower items.
The goal of imaginal and in vivo exposure is to help patients process the traumatic memories and correct erroneous cognitions about the world and the self.
1. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry. 1995;52:1048-1060.
2. Foa EB, Meadows EA. Psychosocial treatments for posttraumatic stress disorder: a critical review. Ann Rev Psychol. 1997;48:449-480.
3. Foa EB, Ehlers A, Clark D, Tolin DF. Posttraumatic cognitions inventory (PTCI): development and comparison with other measures. Psychol Assess. 1999;11:303-314.
4. Shapiro F. Eye Movement Desensitization and Reprocessing: Basic Principles, Protocols, and Procedures. New York: Guilford; 2001.
5. Barlow DH. Anxiety and Its Disorders: The Nature and Treatment of Anxiety and Panic. 2nd ed. New York: Guilford; 2002.
6. Foa EB, Rothbaum BO. Treating the Trauma of Rape: Cognitive-Behavior Therapy for PTSD. New York: Guilford; 1998.
7. Meichenbaum DH. Stress Inoculation Training. New York: Pergamon Press; 1985.
8. Veronen LJ, Kilpatrick DG. Stress management for rape victims. In: Meichenbaum D, Jaremko ME, eds. Stress Reduction and Prevention. New York: Plenum Press; 1983:341-374.
9. Foa EB, Rothbaum RO, Riggs DS, Murdock TB. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling. J Consult Clin Psychol. 1991;59:715-723.
10. Foa EB, Dancu CV, Hembree EA, et al. A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims. J Consult Clin Psychol. 1999; 67:194-200.
11. Beck AT. Cognitive Therapy and the Emotional Disorders. New York: International Universities Press; 1976.
12. Beck AT, Emery G, Greenberg RL. Anxiety Disorders and Phobias: A Cognitive Perspective. New York: Basic Books; 1985.
13. Acierno R, Hersen M, Van Hasselt VB, et al. Review of the validation and dissemination of eye-movement desensitization and reprocessing: a scientific and ethical dilemma. Clin Psychol Rev. 1994;14:287-299.
14. Herbert JD, Mueser KT. Eye movement desensitization: a critique of the evidence. J Behav Ther Exp Psychiatry. 1992;23:169-174.
15. Lohr JM, Kleinknecht RA, Conley AT, et al. A methodological critique of the current status of eye movement desensitization (EMD). J Behav Ther Exp Psychiatry. 1992;23:159-167.
16. Lohr JM, Kleinknecht RA, Tolin DF, et al. The empirical status of the clinical application of eye movement desensitization and reprocessing. J Behav Ther Exp Psychiatry. 1995;26:285-302.
17. Lohr JM, Tolin DF, Lilienfeld SO. Efficacy of eye movement desensitization and reprocessing: implications for behavior therapy. Behav Ther. 1998;29:123-156.
18. Rothbaum BO. A controlled study of eye movement desensitization and reprocessing in the treatment of posttraumatic stress disordered sexual assault victims. Bull Menninger Clin. 1997;61:317-334.
19. Rothbaum BO, Astin MC, Marsteller F. Prolonged exposure versus eye movement desensitization and reprocessing (EMDR) for PTSD rape victims. J Traumatic Stress. 2005;18:607-616.
20. Cahill SP, Carrigan MH, Frueh BC. Does EMDR work? And if so, why? A critical review of controlled outcome and dismantling research. J Anxiety Disord. 1999;13:5-33.
21. Bradley R, Greene J, Russ E, et al. A multidimensional meta-analysis of psychotherapy for PTSD. Am J Psychiatry. 2005;162:214-227.
22. Cahill SP, Rauch SA, Hembree EA, Foa EB. Effect of cognitive behavioral treatment for PTSD on anger. J Cognitive Psychother. 2003;17:113-131.
23. Kubany ES, Hill EE, Owens JA. Cognitive trauma therapy for battered women with PTSD: preliminary findings. J Traumatic Stress. 2003;16:81-91.
24. Becker, Becker CB, Zayfert C, Anderson E. A survey of psychologists' attitudes towards and utilization of exposure therapy for PTSD. Behav Res Ther. 2004;42:277-292.
25. Marks I, Lovell K, Noshirvani H, et al. Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring. Arch Gen Psychiatry. 1998;55:317-325.
26. Paunovic N, Ost LG. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001;39:1183-1197.
27. Foa EB, Hembree EA, Cahill SP, et al. Randomized trial of prolonged exposure for PTSD with and without cognitive restructuring: outcome at academic and community clinics. J Consult Clin Psychol. 2005;73:953-964.
28. Bryant RA, Moulds ML, Guthrie RM, et al. Imaginal exposure alone and imaginal exposure with cognitive restructuring in treatment of posttraumatic stress disorder. J Consult Clin Psychol. 2003;71:706-712.
29. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder. JAMA. 2000;283:1837-1844.
30. Davidson JRT, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001;58:485-492.
31. Marshall RD, Beebe KL, Oldham M, Zaninelli R. Efficacy and safety of paroxetine treatment of chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158:1982-1988.
32. Tucker P, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial. J Clin Psychiatry. 2001;62:860-868.
33. Rothbaum BO, Cahill SP, Foa EB, et al. Augmentation of sertraline with prolonged exposure in the treatment of PTSD. J Traumatic Stress. 2006;19:625-638.
34. Cahill SP, Hembree EA, Foa EB. Dissemination of prolonged exposure therapy for posttraumatic stress disorder: successes and challenges. In: Neria Y, Gross R, Marshall R, Susser E, eds. 9/11: Mental Health in the Wake of Terrorist Attacks. Cambridge, United Kingdom: Cambridge University Press; 2006:475-495.
35. Cahill SP, Foa EB, Hembree EA, et al. Dissemination of exposure therapy in the treatment of PTSD. J Traumatic Stress. 2006;19:597-610.